These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2778256)

  • 1. Control of nephrotoxicity in the rat during repeated cis-platinum treatments.
    Jones MM; Basinger MA
    J Appl Toxicol; 1989 Aug; 9(4):229-33. PubMed ID: 2778256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
    Jones MM; Basinger MA; Mitchell WM; Bradley CA
    Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dithiocarbamate-induced biliary platinum excretion and the control of cis-platinum nephrotoxicity.
    Basinger MA; Jones MM; Gilbreath SG; Walker EM; Fody EP; Mayhue MA
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):279-88. PubMed ID: 2538006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS; Riviere JE
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of some aspects of cis-platinum nephrotoxicity.
    Jones MM; Basinger MA; Craft WD; Domingo JL; Llobet JM
    Arch Toxicol; 1986 Oct; 59(3):167-71. PubMed ID: 3028320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
    Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
    Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
    Reznik LV; Myazina EM; Shakchmatova EI; Gambaryan SP; Brovtsyn VK; Natochin YV; Jones MM
    Br J Cancer; 1991 Feb; 63(2):234-6. PubMed ID: 1847647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
    Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
    J Appl Toxicol; 1995; 15(4):267-73. PubMed ID: 7594195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
    Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
    J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
    Nagai N; Hotta K; Yamamura H; Ogata H
    Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
    Zhang JS; Imai T; Otagiri M
    Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.
    Graziano J; Jones B; Pisciotto P
    Br J Pharmacol; 1981 Jul; 73(3):649-54. PubMed ID: 6265016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
    Hannemann J; Baumann K
    Arch Toxicol; 1990; 64(5):393-400. PubMed ID: 2169720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity.
    Jones MM; Basinger MA; Holscher MA
    Toxicology; 1991; 68(3):227-47. PubMed ID: 1896997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
    Hanada K; Odaka K; Kudo A; Ogata H
    Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
    Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
    Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of N-benzyl-D-glucamine dithiocarbamate against renal toxicity in rats during repeated cis-diamminedichloroplatinum administrations.
    Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
    Ren Fail; 1995 Sep; 17(5):539-50. PubMed ID: 8570866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
    Hidaka S; Tsuruoka M; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
    Ren Fail; 1994; 16(3):337-49. PubMed ID: 8059017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.